US FDA establishes cGMP requirements for PET drugs
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has issued a final rule establishing current good manufacturing practice requirements for positron emission tomography (PET) drugs, effective 12 December 20111,2.